These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Estimation of permeability in blood-retinal barrier. Kojima M; Yoshida A; Ishiko S; Tanaka K Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794 [TBL] [Abstract][Full Text] [Related]
25. Transmission electron microscopic observations of vitreous abnormalities in retinitis pigmentosa. Albert DM; Pruett RC; Craft JL Am J Ophthalmol; 1986 Jun; 101(6):665-72. PubMed ID: 3717249 [TBL] [Abstract][Full Text] [Related]
26. Outward transport of fluorescein from the vitreous in normal human subjects. Blair NP; Zeimer RC; Rusin MM; Cunha-Vaz JG Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634 [TBL] [Abstract][Full Text] [Related]
27. The correlation of the results of vitreous fluorophotometry and fluorescein angiography in nonproliferative diabetic retinopathy. Stur M; Reitner A; Irsigler K Retina; 1988; 8(1):50-4. PubMed ID: 3406544 [TBL] [Abstract][Full Text] [Related]
28. Vitreous degeneration in myopia and retinitis pigmentosa. Pruett RC; Albert DM Bull Soc Belge Ophtalmol; 1987; 223 Pt 1():211-28. PubMed ID: 3307966 [No Abstract] [Full Text] [Related]
29. [Changes in the vitreous body in retinal pigment dystrophy]. Shershevskaia SF; Eremenko AI Oftalmol Zh; 1980; 35(8):461-3. PubMed ID: 7207937 [No Abstract] [Full Text] [Related]
30. [Retinitis pigmentosa and vitreo-macular traction syndrome. An anatomo-clinical and histopathological study apropos of a case]. Gastaud P; Rouhette H; Negre F; Betis F; Darmon J; Hofman P J Fr Ophtalmol; 1999; 22(7):766-70. PubMed ID: 10510757 [TBL] [Abstract][Full Text] [Related]
32. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement. Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315 [TBL] [Abstract][Full Text] [Related]
33. Retinal fluorescein leakage in retinitis pigmentosa. Newsome DA Am J Ophthalmol; 1986 Mar; 101(3):354-60. PubMed ID: 3953729 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of fluorescein in the vitreous. Palestine AG; Brubaker RF Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343 [TBL] [Abstract][Full Text] [Related]
35. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats. Kaufmann F; Lacoste C Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774 [TBL] [Abstract][Full Text] [Related]
36. Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye. Larsen M; Engler CB; Haim M; Lund-Andersen H Int Ophthalmol; 1997-1998; 21(4):229-34. PubMed ID: 9700011 [TBL] [Abstract][Full Text] [Related]
37. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure. Roy MS; Bungay PM; Bonner RF Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803 [TBL] [Abstract][Full Text] [Related]
38. Carriers of X-linked recessive retinitis pigmentosa: investigation by vitreous fluorophotometry. Fishman GA; Cunha-Vaz JE Int Ophthalmol; 1981 Aug; 4(1-2):37-44. PubMed ID: 7197669 [TBL] [Abstract][Full Text] [Related]